基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Objective To provide reference for the development strategy of China’s enterprises under the current policy background of generic drug consistency evaluation and volume procurement.Methods China’s current policies on generic drugs and market environment were analyzed and the development paths of international top pharmaceutical enterprises were studied as well.Results and Conclusion There are four transformation and upgrading paths for China’s pharmaceutical enterprises.First,they should invest more in innovation to realize the globalization of new drugs.Second,overseas patented new drugs should be introduced actively.Third,they must focus on the research and development of high-end generic drugs.Lastly,the transformation from active pharmaceutical ingredients into pharmaceutic preparation should be carried out quickly.Under the background of volume procurement,the pharmaceutical market pattern will be completely changed.The research and development capability and patented drugs will become the core competitive advantages of enterprises.
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Analysis on the Development Strategy of China’s Pharmaceutical Enterprises under the Background of Volume Procurement
来源期刊 亚洲社会药学 学科 经济
关键词 volume procurement generic drug pharmaceutical enterprise
年,卷(期) 2020,(4) 所属期刊栏目
研究方向 页码范围 193-197
页数 5页 分类号 F42
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2020(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
volume
procurement
generic
drug
pharmaceutical
enterprise
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
亚洲社会药学
季刊
1818-0884
辽宁省沈阳市沈河区文化路103号
出版文献量(篇)
76
总下载数(次)
0
总被引数(次)
0
论文1v1指导